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Sir: we read with interest the contri-
bution by Trevisanuto et al. [1] on the
effectiveness of a new device for
administering continuous positive
airway pressure (CPAP) as an alter-
native to conventional nasal CPAP in
ameliorating comfort in preterm in-
fants needing continuous distending
pressure. The data which they present
are intriguing, but a few points need
to be further discussed. First, the use
of a “comfort scale” appears to be a
surrogate end-point. To properly as-
sess safety and efficacy of this new
technique, even in a pilot study, the
authors should have focused on more
relevant clinical aspects or potential
complications, such as level of res-
piratory distress, oxygen-dependen-
cy, rate of apnea, local damage, air
leak, or need for mechanical ventila-
tion.
Second, the authors reported a
marked reduction in the Neonatal
Infant Pain Scale (NIPS) values, i.e.,
a better comfort status of patients,
during treatment with helmet CPAP.
Given the lower level of stress im-
posed by this technique, one might
have expected some modifications in
the main physiological parameters,
such as heart rate, respiratory rate,
and arterial blood pressure [2]. On the
other hand, none of the investigated
parameters differed between the two
CPAP treatments, raising doubts
about potential bias due to the non-
blinded scoring method used in this
study. Indeed, NIPS does require a
close observation of the infant, mak-
ing any blinding process quite com-
plex. Such important limitation might
be partially circumvented by simul-
taneous NIPS measurements per-
formed by two independent observers
or by video recording.
Third, the small number of en-
rolled patients (powered only for the
chosen end-point), the very brief du-
ration of both CPAP treatments, and
the relatively healthy status of the
population studied preclude any de-
finitive conclusion about this study.
Indeed, how would this technique
work in sicker infants who may re-
quire CPAP continuously for days or
weeks? What are the possible effects
of long-term application on abdomi-
nal distension, or in the prevention of
apnea episodes?
As regards the latter point, we
have had the contrary findings in a
single preliminary experience. A
premature infant (31weeks of post-
conceptional age) treated with con-
ventional nasal CPAP (Infant-Flow-
Driver, EME) for apnea of prematu-
rity, was shifted to helmet CPAP due
to poor tolerance of nasal prongs.
However, after 2 h of treatment he
had to be returned to nasal CPAP for
repeated episodes of apnea and arte-
rial O2 desaturation. Interestingly, as
soon as conventional nasal CPAP was
applied, the apneic episodes virtually
disappeared. Of note, we report some
difficulties in maintaining CPAP
levels above 3 cmH2O, despite flow
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rates set as high as 15 lpm and ab-
sence of major leaks in the system.
We speculate that conventional nasal
CPAP, successfully used for apnea of
prematurity [3], would be more ef-
fective than the new technique in
these circumstances.
In summary, we congratulate the
authors for their original study.
Nonetheless, their conclusion that the
helmet CPAP “seems to guarantee a
better tolerability and at least similar
improvement in oxygenation” may be
misleading for the reader. We believe
that larger randomized controlled
studies are needed to better define the
role of this new device and to verify
its potential superiority over conven-
tional CPAP by means of more ap-
propriate end-points.
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